Short hairpin RNA attenuates liver fibrosis by regulating the PPAR‑γ and NF‑κB pathways in HBV‑induced liver fibrosis in mice.

Abstract

Progressive liver fibrosis, caused by chronic viral infection and metabolic disorders, results in the development of cirrhosis and hepatocellular carcinoma. However, no antifibrotic therapies have been approved to date. In our previous study, adeno‑associated virus (AAV) short hairpin RNAs (shRNAs) targeting hepatitis B virus (HBV) and transforming growth factor (TGF)‑β administration could persistently inhibit HBV replication and concomitantly prevent liver fibrosis. However, the differentially expressed proteins and critical regulatory networks of AAV‑shRNA treatment remain unclear. Accordingly, in the present study, we aimed to analyze differentially expressed proteins in the liver of AAV‑shRNA‑treated mice with HBV infection and liver fibrosis using isobaric tags for relative and absolute quantitation (iTRAQ)‑based quantitative proteomics and to elucidate the underlying antifibrotic mechanisms. In total 2,743 proteins were recognized by iTRAQ‑based quantitative proteomics analysis. Gene Ontology analysis revealed that the differentially expressed proteins mostly participated in peptide metabolism in the biological process category, cytosolic ribosomes in the cell component category, and structural constituents of ribosomes in the molecular function category. Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated that oxidative stress and the peroxisome proliferator‑activated receptor (PPAR) signaling pathway were activated after treatment. Verification studies revealed that AAV‑shRNAs inhibited hepatic stellate cell activation and inflammation by suppressing nuclear factor‑κB p65 phosphorylation and α‑smooth muscle actin expression via upregulation of PPAR‑γ. Hepatocytes steatosis was also decreased by activating the PPAR signaling pathway and improving lipid metabolism. The expression level of TGF‑β was decreased due to upregulation of PPAR‑γ expression and direct inhibition using AAV‑shRNA targeting TGF‑β. TGF‑β‑induced oxidative stress was suppressed by increasing glutathione S‑transferase Pi 1 and reducing peroxiredoxin 1. Collectively, the present results indicated that AAV‑shRNAs were effective in modulating liver fibrosis by reducing oxidative stress, inflammation and activating the PPAR signaling pathway.

• Authors: Lei Ye, Ting Chen, Jiaqi Cao, Liying Sun, Wuping Li, Chenghai Zhang
• Journal: International journal of oncology (Int J Oncol) Vol. 57 Issue 5 Pg. 1116-1128 (11 2020) ISSN: 1791-2423 [Electronic] Greece
• PMID: 33491741 (Publication Type: Journal Article)

Chemical References

• Interleukin-6
• NF-kappa B
• PPAR gamma
• RNA, Small Interfering
• Transforming Growth Factor beta

Topics

• Animals
• Cell Line
• Dependovirus (genetics)
• Hepatitis B (complications)
• Interleukin-6 (blood)
• Liver Cirrhosis, Experimental (etiology, therapy)
• Male
• Mice
• Mice, Inbred C57BL
• NF-kappa B (physiology)
• Oxidative Stress
• PPAR gamma (physiology)
• Proteomics
• RNA, Small Interfering (genetics)
• Signal Transduction (physiology)
• Transforming Growth Factor beta (genetics)